Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Quadruple-threat Rheumatologist

Gretchen Henkel  |  Issue: October 2010  |  October 1, 2010

I have become quite a different doctor than I had imagined I should ever be,” reflects Tore K. Kvien, MD, PhD, professor of rheumatology at the University of Oslo, head of the department of rheumatology at Diakonhjemmet Hospital in Oslo, Norway, and past president of the European League Against Rheumatism (EULAR).

In a recent telephone interview, Dr. Kvien reveals he originally planned to become a family doctor. But even when he gravitated to rheumatology, his initial vision—to become a good clinician—has informed his leadership in his chosen specialty. Throughout his career, Dr. Kvien has devoted his scientific intelligence to advancing patient care. With nearly 300 scientific papers recorded in PubMed and leadership roles in major national and international rheumatology organizations, he has won renown for establishing his country’s first longitudinal patient database, for conducting wide-ranging collaborative research, and for fostering productive international initiatives.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The First Road

Dr. Kvien knew that medicine was for him even during his teenage years, he recalls. Diligent work and support from his parents helped to make that dream come true. Shortly after obtaining his medical school certification, he says, “I wanted to have some hospital practice, because that was relevant to becoming a family doctor.” He also knew that musculoskeletal diseases comprised the most frequent problems for which patients sought medical care, so he chose to train at Sørlandet Rheumatism Hospital from 1976 to 1978. During that time, his interest in the general practice of medicine morphed into a fascination with rheumatology. He subsequently spent four years at Oslo Sanitetsforening Rheumatism Hospital, the last 10 months of which were as head of the Pediatric Rheumatology Department.

Dr. Kvien receiving a Festschrift (celebration book with articles). Above, photo of Oslo, Norway.
Dr. Kvien receiving a Festschrift (celebration book with articles). Above, photo of Oslo, Norway.

While there, Dr. Kvien was under the tutelage of pediatric rheumatologist Hans Martin Høyerall, MD, PhD, who gave him the opportunity to take responsibility for an industry-independent randomized controlled clinical trail program in juvenile arthritis. This work formed the cornerstone of Dr. Kvien’s PhD thesis, “Drug management of patients with juvenile rheumatoid arthritis.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To become a rheumatology consultant required additional training, which he acquired in the departments of medicine, cardiology, nephrology, and neurology in various hospitals in Oslo during the following year. Dr. Kvien then accepted a position as a rheumatology consultant at Diakonhjemmet. His experience with a spectrum of clinical practice offered opportunities in his new position for collaboration between rheumatology and other disciplines, such as nephrology.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Professional TopicsProfilesResearch Rheum Tagged with:CareerDatabaseResearchRheumatoid arthritis

Related Articles

    Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

    September 1, 2013

    Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology

    Potential Benefits, Pitfalls of Biosimilars Reviewed at EULAR 2016

    September 8, 2016

    LONDON—The availability of a bio­similar form of infliximab has dramatically increased the number of Norwegians taking one form or another of the drug, an expert on biosimilars said in a debate-style session at the Annual Congress of the European League Against Rheumatism (EULAR 2016). The expanded uptake of Remicade (infliximab) and its biosimilar, Remsima (international…

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    The ACR/ARHP Awards Members for Contributions to Rheumatology

    December 15, 2015

    San Francisco is known for the Gold Rush, so it’s a particularly fitting place to collect a gold nugget. And so at the 2015 ACR/ARHP Annual Meeting in the Golden Gate City in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences